HomeAgenda
Register
Register
Register

Covalab

Company (SME/startup) / 中小企業・スタートアップ

www.covalab.com/Bron, France
3 profile visits

About

Founded in 1995, Covalab is a French biotechnology company renowned for its expertise in antibody engineering. With over three decades of experience, Covalab specializes in the design and development of a wide range of antibodies, including polyclonal, monoclonal, scFv, FAb, VHH, and recombinant antibodies, utilizing advanced techniques such as DNA immunization.​ ​

The company offers a fully integrated platform for antibody generation, with customizable services tailored to specific research, diagnostic, and therapeutic needs. Its expertise spans diverse fields including cancer research, neuroscience, and autoimmune diseases.​ ​

Covalab’s comprehensive approach includes a careful immunogen and animal host selection, rigorous screening processes, and state- of-the-art characterization. Committed to quality, the company holds ISO 9001:2015 certification, reflecting its dedication to excellence in services, products, and R&D.​ ​

Social media

Business Domain / 分野

Pharmaceuticals / 医薬品Foods / 食品

Business Type / 業種

R&D / 研究開発CRO (Preclinical) / 開発業務受託(非臨床)CMO, CDMO / 製造受託、開発製造受託

Disease Area / 疾患領域

Oncology / がんImmunology / 免疫・炎症

Modalities / モダリティ

Antibody drug / 抗体医薬

Technologies / 技術

Biomarkers /バイオマーカーOthers / その他

Additional questions

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等(インライセンス、共同研究などを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がんImmunology / 免疫・炎症

Researched Modality / マッチングご希望のモダリティ

Antibody drug / 抗体医薬

Researched Technologies / マッチングご希望の技術

Biomarkers / バイオマーカーOthers /その他